More than five million Canadians are immunocompromised, yet their experiences and needs are not always reflected in health policies, public health strategies, or access to care. Gaps in vaccine and treatment access, health information, and infection prevention highlight the need for a stronger, more unified national voice to bring these issues forward and turn lived experience into meaningful action.
“Immunocompromised Canadians deserve to have their voices heard and their needs reflected in healthcare decisions.
By coming together, we can advocate for more equitable access, stronger protections, and better health outcomes for our communities.”
A coalition that brings people together to drive change.
Praxus Health established and supports CIAN as a national network that connects patient voices, advocacy organizations, and healthcare providers.
Through strategic coordination, communications, research, and coalition-building, we help create the infrastructure for collective advocacy and sustained progress.
We developed a position paper informed by first-hand experiences and comprehensive research, calling for targeted strategies to better protect immunocompromised Canadians, including:
Bringing lived experiences into the conversation. We amplify patient stories and perspectives to build public understanding of the challenges facing immunocompromised Canadians.
Turning collective voices into action. We work with members and partners to advance equitable access to vaccines, treatments and policies that better protect immunocompromised people.
Making trusted information more accessible. We develop educational resources that help people navigate health information, understand their options and make informed decisions.
CIAN Co-Chair
CIAN Co-Chair
Through targeted advocacy and collaboration, CIAN is helping drive meaningful progress on issues affecting immunocompromised Canadians, including:
Expanded COVID-19 Vaccine Options
After two years of advocacy campaigns, support from 31 patient organizations, responses from 8 provinces and meetings with two provinces, all 10 provinces and the Yukon are making Nuvaxovid, a protein-based COVID-19 vaccine available across Canada. This expands vaccine choice and provides immunocompromised Canadians with more options to support their individual health needs.
A social media post, a news headline, or a conversation in an online patient group can shape how we understand our health.
For many people, COVID-19 vaccination is straightforward. For others, the decision to get vaccinated can involve more questions and considerations.
As respiratory virus season begins across Canada, it’s a good time to get informed about what protection options are available for RSV.
